Patents by Inventor Andrew Simons

Andrew Simons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11339151
    Abstract: The present invention relates to a compound represented by formula (1): the compound having antagonist activity against serotonin 5-HT2A receptors and serotonin 5-HT7 receptors; or a pharmaceutically acceptable salt of the compound. (In the formula, Z is a nitrogen atom and the like; Y is carbonyl and the like; m and n are 1 and the like; R1a through R1d, R2a through R2d, and R4a through R4d are a hydrogen atom and the like; R3 is alkyl and the like; and Q is a specific bicyclic group.
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: May 24, 2022
    Assignee: SUMITOMO DAINIPPON PHARMA CO., LTD.
    Inventors: Yuki Fujii, Masayuki Sakuma, Yoshinori Aihara, Jeremy Besnard, Andrew Simon Bell
  • Publication number: 20220073506
    Abstract: The present invention relates to a compound represented by formula (1): the compound having antagonist activity against serotonin 5-HT2A receptors and serotonin 5-HT7 receptors; or a pharmaceutically acceptable salt of the compound. (In the formula, Z is a nitrogen atom and the like; Y is carbonyl and the like; m and n are 1 and the like; R1a through R1d, R2a through R2d, and R4a through R4d are a hydrogen atom and the like; R3 is alkyl and the like; and Q is a specific bicyclic group.
    Type: Application
    Filed: November 17, 2021
    Publication date: March 10, 2022
    Applicant: Sumitomo Dainippon Pharma Co., Ltd.
    Inventors: Yuki FUJII, Masayuki SAKUMA, Yoshinori AIHARA, Jeremy BESNARD, Andrew Simon BELL
  • Publication number: 20220064158
    Abstract: The invention provides inter alia compound as defined herein and its use in the prevention or treatment of a disease or disorder in which inhibition of N-myristoyl transferase provides a therapeutic or prophylactic effect, e.g. cancer.
    Type: Application
    Filed: December 19, 2019
    Publication date: March 3, 2022
    Applicant: IMPERIAL COLLEGE INNOVATIONS LIMITED
    Inventors: Edward William TATE, Andrew Simon BELL
  • Publication number: 20220056013
    Abstract: The present disclosure provides compounds and methods useful for inhibiting SARM1 and/or treating and/or preventing axonal degeneration.
    Type: Application
    Filed: August 23, 2021
    Publication date: February 24, 2022
    Inventors: Todd BOSANAC, Andrew Simon BREARLEY, Rajesh DEVRAJ, Robert Owen HUGHES, Richard Andrew JARJES-PIKE, Shelley Anne PARROTT
  • Publication number: 20220046803
    Abstract: An electrical assembly which comprises a substrate and a conformal coating deposited on at least one surface of the substrate by plasma polymerization of a compound of formula (I) and deposition of a resulting polymer of the compound of formula (I), and plasma polymerization of a fluorohydrocarbon and deposition of a resulting polymer of the fluorohydrocarbon, such that the resulting polymer of the compound of formula (I) and the resulting polymer of the fluorohydrocarbon create discrete layers of the conformal coating; wherein the compound of formula (I) is an organic compound.
    Type: Application
    Filed: October 20, 2021
    Publication date: February 10, 2022
    Inventors: Andrew Simon Hall Brooks, Timothy Allan Von Werne
  • Patent number: 11211115
    Abstract: A random access memory array including a plurality of local memory group ways, each local memory group way including, a plurality of local memory groups, each local memory group including, a memory column including a plurality of memory cells, a pair of local bitlines operatively connected to the plurality of memory cells, and a local group periphery including a local bitline multiplexer operatively connected with the pairs of local bitlines of the corresponding local memory group; and a pair of global read bitlines operatively connected to outputs of the plurality of local group peripheries, a global read bitline multiplexer operatively connected to outputs of the plurality of pairs of the global read bitlines from the local memory group ways, and a bitline operational block operatively connected an output of the global read bitline multiplexer.
    Type: Grant
    Filed: May 5, 2020
    Date of Patent: December 28, 2021
    Assignee: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
    Inventors: Marco Antonio Rios, William Andrew Simon, Alexandre Sébastien Levisse, Marina Zapater, David Atienza Alonso
  • Publication number: 20210350846
    Abstract: A random access memory array including a plurality of local memory group ways, each local memory group way including, a plurality of local memory groups, each local memory group including, a memory column including a plurality of memory cells, a pair of local bitlines operatively connected to the plurality of memory cells, and a local group periphery including a local bitline multiplexer operatively connected with the pairs of local bitlines of the corresponding local memory group; and a pair of global read bitlines operatively connected to outputs of the plurality of local group peripheries, a global read bitline multiplexer operatively connected to outputs of the plurality of pairs of the global read bitlines from the local memory group ways, and a bitline operational block operatively connected an output of the global read bitline multiplexer.
    Type: Application
    Filed: May 5, 2020
    Publication date: November 11, 2021
    Inventors: Marco Antonio Rios, William Andrew Simon, Alexandre Sébastien Levisse, Marina Zapater, David Atienza Alonso
  • Publication number: 20210331646
    Abstract: The present disclosure relates to aspects of authenticating a mobile device and providing a vehicle access key thereto when a previously registered mobile device is not accessible. In one aspect of the present disclosure, a method includes requesting at a first mobile device, access to a profile associated with controlling operations of a vehicle, the profile having stored thereon an access key for operating the vehicle, the access key having been previously installed on a second mobile device. The method further includes upon successful authorization, receiving the access key at the first device and operating the vehicle using the access key on the first mobile device.
    Type: Application
    Filed: April 23, 2020
    Publication date: October 28, 2021
    Applicant: Ford Global Technologies, LLC
    Inventors: Jochen Schubert, Tom Nelson, Michael Andrew Simons, Ali Hassani, Hamid Golgiri, John Robert Van Wiemeersch
  • Publication number: 20210325661
    Abstract: Provided herein is a modulating retroreflective multilayer film comprising retroreflective elements, a piezoelectric layer, a photovoltaic layer, and an energy storage device. The stacked and transparent layered configuration of the film allows the retroreflective elements and the photovoltaic layer to be simultaneously illuminated by a narrow beam. The low power piezoelectric layer and the energy harvesting of the photovoltaic layer allow the retroreflector to be energetically self-sufficient and suitable for remote deployment. The flexible properties of the component layers allow the retroreflector to be adhered to nonplanar or irregular surfaces for the purpose of labeling and tagging.
    Type: Application
    Filed: July 1, 2021
    Publication date: October 21, 2021
    Inventor: Andrew Simon FILO
  • Publication number: 20210261540
    Abstract: The present disclosure provides compounds and methods useful for inhibiting SARM1 and/or treating and/or preventing neurodegenerative disease or axonal degeneration. The provided SARM1 inhibitors may reduce or inhibit binding of NAD+ by SARM1. Alternatively, provided SARM1 inhibitors bind to SARM1 within a pocket comprising one or more catalytic residues (e.g., a catalytic cleft of SARM1).
    Type: Application
    Filed: June 6, 2019
    Publication date: August 26, 2021
    Inventors: Robert Owen Hughes, Rajesh Devraj, Todd Bosanac, Richard Andrew Jarjes-Pike, Andrew Simon Brearley, Jonathan Bentley
  • Publication number: 20210261537
    Abstract: The present disclosure provides compounds and methods useful for inhibiting SARMI and/or treating and/or preventing axonal degeneration. Provided SARMI inhibitors reduce or inhibit binding of NAD+ by SARMI and SARMI inhibitors bind to SARMI within a pocket comprising one or more catalytic residues (e.g., a catalytic cleft of SARMI).
    Type: Application
    Filed: June 6, 2019
    Publication date: August 26, 2021
    Inventors: Robert Owen Hughes, Rajesh Devraj, Todd Bosanac, Richard Andrew Jarjes-Pike, Andrew Simon Brearley, Jonathan Bentley
  • Patent number: 11101915
    Abstract: The subject method for delivering power to a moving target wirelessly via electromagnetic time reversal can find applications in wireless electrical transmission to portable devices, wireless heating of portable devices, novel wirelessly powered accelerometers, hyperthermic treatment of cancers, and many other applications. The subject non-linear time reversed electromagnetic waves based wireless power transmission (WPT) system targets either a single linear or non-linear object where a selective targeting between two diodes has been demonstrated simultaneously with different degrees of non-linearity in a three-dimensional ray-chaotic billiard model. A dual-purpose rectenna with harmonic generation for wireless power transfer by non-linear time-reversal has been designed for the subject system using the Schottky diode.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: August 24, 2021
    Assignee: University of Maryland, College Park
    Inventors: Steven Mark Anlage, Frank Cangialosi, Tyler Grover, Andrew Simon, Scott Roman, Liangcheng Tao
  • Publication number: 20210251995
    Abstract: The invention provides a compound of formula (I), or pharmaceutically acceptable ester, amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or carbamate, wherein R1 is an optionally substituted phenyl, or an optionally substituted 5- or 6-membered aromatic heterocycle; and R2 is an optionally substituted 5- or 6-membered aromatic heterocycle. Also provided are pharmaceutical compositions comprising a compound of formula (I).
    Type: Application
    Filed: June 4, 2019
    Publication date: August 19, 2021
    Applicants: EXSCIENTIA LTD.,, EVOTEC INTERNATIONAL GMBH
    Inventors: Andrew Simon BELL, Adrian Michael SCHREYER, Stephanie VERSLUYS
  • Patent number: 11094355
    Abstract: A random access memory having a memory array having a plurality of local memory groups, each local memory group including a plurality of bitcells arranged in a bitcell column, a pair of local bitlines operatively connected to the plurality of bitcells, a pair of global read bitlines, a local group read port arranged between the pair of local bitlines and the pair of global read bitlines for selectively accessing one of the local bitlines depending on a state of a selected bitcell, and a local group precharge circuit operatively arranged between the pair of local bitlines.
    Type: Grant
    Filed: May 5, 2020
    Date of Patent: August 17, 2021
    Assignee: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
    Inventors: William Andrew Simon, Marco Antonio Rios, Alexandre Sébastien Levisse, Marina Zapater, David Atienza Alonso
  • Patent number: 11079590
    Abstract: Provided herein is a modulating retroreflective multilayer film comprising retroreflective elements, a piezoelectric layer, a photovoltaic layer, and an energy storage device. The stacked and transparent layered configuration of the film allows the retroreflective elements and the photovoltaic layer to be simultaneously illuminated by a narrow beam. The low power piezoelectric layer and the energy harvesting of the photovoltaic layer allow the retroreflector to be energetically self-sufficient and suitable for remote deployment. The flexible properties of the component layers allow the retroreflector to be adhered to nonplanar or irregular surfaces for the purpose of labeling and tagging.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: August 3, 2021
    Assignee: Andrew Simon FILO
    Inventor: Andrew Simon Filo
  • Publication number: 20210230169
    Abstract: The present invention relates to compounds and pharmaceutically acceptable salts or solvates thereof for use in the treatment or prevention of fascioliasis. Some of these compounds are novel per se and also have activity as inhibitors of Schistosoma growth. The invention also relates to pharmaceutical compositions comprising such novel compounds, salts or solvates and to the use of such novel compounds as medicaments, in particular in the treatment or prevention of schistosomiasis, also known as bilharzia.
    Type: Application
    Filed: July 16, 2019
    Publication date: July 29, 2021
    Inventors: John Mark Francis Gardner, Andrew Simon Bell
  • Publication number: 20210231538
    Abstract: A method of processing a biological sample to obtain single cells and/or groups of cells comprises: fixing cells of the biological sample using a fixative; contacting the biological sample with a dissociation medium; dissociating the biological sample in the presence of the dissociation medium to obtain the single cells and/or groups of cells; wherein the fixative comprises a deep eutectic solvent. Fixing cells of the biological sample using a deep eutectic solvent facilitates dissociation of the biological sample into single cells, while at the same time inhibiting the degradation of biomolecules such as DNA and RNA in the cells. Also provided is an apparatus useful in the method, deep eutectic solvents and uses thereof, and a method of extracting cell nuclei.
    Type: Application
    Filed: July 23, 2019
    Publication date: July 29, 2021
    Inventors: Andrew Simon GOLDSBOROUGH, Malcom Robert BATES
  • Patent number: 11046700
    Abstract: The present invention relates to compounds of formula (1a), formula (1b), formula (1c) or formula (1d): or, or a pharmaceutically acceptable salt thereof, which have activity as inhibitors of Schistosoma growth. The invention also relates to pharmaceutical compositions comprising such compounds, salts or solvates and to the use of such compounds as medicaments, in particular in the treatment or prevention of schistosomiasis, also known as bilharzia.
    Type: Grant
    Filed: January 15, 2018
    Date of Patent: June 29, 2021
    Assignee: Merck Patent GmbH
    Inventors: John Mark Francis Gardner, Andrew Simon Bell
  • Patent number: 11021135
    Abstract: A system includes a processor configured to wirelessly communicate with a mobile device application. The processor is further configured to receive a vehicle-command from the mobile device application and send a wireless instruction to a vehicle instructing an action corresponding to and responsive to the received vehicle command.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: June 1, 2021
    Assignee: Ford Global Technologies, LLC
    Inventors: David Martin Gersabeck, David Anthony Hatton, Ziad Alhihi, Michael Andrew Simons, Thomas Nelson, Ryan Conroy
  • Patent number: D925433
    Type: Grant
    Filed: February 11, 2018
    Date of Patent: July 20, 2021
    Inventor: Andrew Simon Filo